AI usage framework · Healthcare and pharma
AI usage rules in healthcare and pharma: a guide for group HR directors
In a healthcare group or a pharmaceutical laboratory, the AI-at-work question comes with one red line that admits no ambiguity: patient data and trial data never leave the company.
The rest — regulatory writing, monitoring, sales teams, training — is framed like any mid-cap's, with stronger documentation traceability than elsewhere. This guide covers the usage and what a framework must contain.
What your teams already use
- Regulatory and quality writing
- Procedures, reports and batch documents pre-drafted by quality teams, with a need for version traceability.
- Regulatory monitoring
- Summaries of European changes and guidelines, produced with consumer tools and no verified source.
- Sales and medical affairs
- Emails, call notes, congress preparation: informal everyday use is everywhere.
- Training material
- Training decks and quizzes generated and released, sometimes without subject-matter review.
- Translating protocols and documents
- Internal documents translated for subsidiaries, with a risk on regulatory terminology.
What blocks specifically in your industry
- The patient-data red line
- No patient, trial or pharmacovigilance data may enter a consumer tool. The rule must say so without nuance and without exception.
- Documentation traceability
- In your document processes, a generated version with no review trail is a deviation, not a time saving.
- Monitoring without sources
- A regulatory summary generated without a verified source travels faster than correct information.
- Several jobs, several risk levels
- Production, quality, commercial, support: the rule must distinguish worlds, not treat everyone the same.
What a usage framework must contain for this sector
- An absolute, explicit ban: patient, trial and pharmacovigilance data in no public tool, including to 'anonymise'.
- A version rule: every regulatory or quality document prepared with AI is traced, reviewed and signed by its owner.
- A monitoring rule: every regulatory summary cites its official source, or it does not circulate.
- A rollout per job family: production, quality, commercial and support have neither the same tools nor the same risks.
- A training component: teams know what is banned, what is allowed, and who to ask.
Three typical priorities for a healthcare group
1. Write the red line without ambiguity
Patient and trial data: total ban, including 'just to summarise'. No nuance, no exception.
2. Trace generated documents
Who drafted the first version, who reviewed, who signed: one simple traceability rule that fits your existing processes.
3. Require sources on monitoring
A summary without an official source does not circulate. A one-line rule that changes the quality of everything circulating.
In healthcare, a usage framework must be as sharp as your document processes. The free diagnostic below identifies your three priorities in six questions, before asking for any contact details.
The Eternal Intern pack, for your job
You answer six questions about your job, your tools and your most annoying tasks; you receive a ZIP by email with eight skills and prompts written for your position, plus the setup guide for your own ChatGPT or Claude subscription. €19.99, one-time, nothing subscribed here. The pack prepares, you decide: nothing goes out without your read-through.
Other industries
LUCIDIA is built and run end to end by AI agents on NanoCorp, which is how these guides stay current.
This page supports governance work; it is not legal advice. Consult your own counsel for your specific situation.